<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Data Brief</journal-id><journal-id journal-id-type="iso-abbrev">Data Brief</journal-id><journal-title-group><journal-title>Data in Brief</journal-title></journal-title-group><issn pub-type="epub">2352-3409</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28831408</article-id><article-id pub-id-type="pmc">5554923</article-id><article-id pub-id-type="publisher-id">S2352-3409(17)30372-4</article-id><article-id pub-id-type="doi">10.1016/j.dib.2017.07.070</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics, Genomics and Molecular Biology</subject></subj-group></article-categories><title-group><article-title>Shotgun metagenomic data on the human stool samples to characterize shifts of the gut microbial profile after the <italic>Helicobacter pylori</italic> eradication therapy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Boulygina</surname><given-names>Eugenia A.</given-names></name><email>boulygina@gmail.com</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><name><surname>Markelova</surname><given-names>Maria I.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Khusnutdinova</surname><given-names>Dilyara R.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Siniagina</surname><given-names>Maria N.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Malanin</surname><given-names>Sergey Yu.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Abdulkhakov</surname><given-names>Rustam A.</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Abdulkhakov</surname><given-names>Sayar R.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Chernov</surname><given-names>Vladislav M.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Grigoryeva</surname><given-names>Tatiana V.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib></contrib-group><aff id="aff0005"><label>a</label>Kazan Federal University, 18 Kremlyovskaya, 420008 Russia</aff><aff id="aff0010"><label>b</label>Kazan State Medical University, 49 Butlerova, 420012 Russia</aff><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author. <email>boulygina@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>28</day><month>7</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>10</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>7</month><year>2017</year></pub-date><volume>14</volume><fpage>458</fpage><lpage>461</lpage><history><date date-type="received"><day>20</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>27</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>25</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 The Authors</copyright-statement><copyright-year>2017</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="ab0010"><p>The shotgun sequencing data presented in this report are related to the research article named &#x0201c;Gut microbiome shotgun sequencing in assessment of microbial community changes associated with <italic>H. pylori</italic> eradication therapy&#x0201d; (Khusnutdinova et al., 2016) <xref rid="bib1" ref-type="bibr">[1]</xref>. Typically, the <italic>H. pylori</italic> eradication protocol includes a prolonged two-week use of the broad-spectrum antibiotics. The presented data on the whole-genome sequencing of the total DNA from stool samples of patients before the start of the eradication, immediately after eradication and several weeks after the end of treatment could help to profile the gut microbiota both taxonomically and functionally. The presented data together with those described in Glushchenko et al. (2017) <xref rid="bib2" ref-type="bibr">[2]</xref> allow researchers to characterize the metagenomic profiles in which the use of antibiotics could result in dramatic changes in the intestinal microbiota composition. We perform 15 gut metagenomes from 5 patients with <italic>H. pylori</italic> infection, obtained through the shotgun sequencing on the SOLiD 5500&#x000a0;W platform. Raw reads are deposited in the ENA under project ID PRJEB21338.</p></abstract><kwd-group id="keys0005"><title>Keywords</title><kwd>Human gut microbiota</kwd><kwd><italic>Helicobacter pylori</italic></kwd><kwd>Eradication</kwd><kwd>Antibiotics</kwd></kwd-group></article-meta></front><body><p><bold>Specifications Table</bold><table-wrap id="t0010" position="float"><alt-text id="at0010">Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Subject area</th><th><italic>Biology</italic></th></tr></thead><tbody><tr><td>More specific subject area</td><td><italic>Metagenomics</italic></td></tr><tr><td>Type of data</td><td><italic>DNA sequences</italic></td></tr><tr><td>How data was acquired</td><td><italic>Shotgun DNA sequencing using SOLiD 5500&#x000a0;W platform</italic></td></tr><tr><td>Data format</td><td><italic>Raw</italic></td></tr><tr><td>Experimental factors</td><td><italic>Total DNA extraction from stool samples</italic></td></tr><tr><td>Experimental features</td><td><italic>Single-end read libraries were created from 5&#x000a0;&#x003bc;g of total DNA. Shotgun metagenomic sequencing was performed on SOLiD 5500&#x000a0;W platform according to the recommendations of the manufacturer.</italic></td></tr><tr><td>Data source location</td><td><italic>Kazan, Russian Federation</italic></td></tr><tr><td>Data accessibility</td><td><italic>Data are available from ENA under project accession number PRJEB21338</italic></td></tr></tbody></table></table-wrap></p><p><bold>Value of the data</bold><list list-type="simple"><list-item id="u0005"><label>&#x02022;</label><p>The data allow researchers to evaluate changes in the taxonomic and functional composition of the human gut microbiota, which is associated with the use of amoxicillin and clarithromycin.</p></list-item><list-item id="u0010"><label>&#x02022;</label><p>Since the data include the metagenome profile at the 3rd time point (several weeks after the end of <italic>H. pylori</italic> eradication), it is possible to make assumptions about the reversibility/irreversibility of therapy-related changes.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>The data can be used to estimate the distribution of antibiotic resistance genes in the genetic pool of the gut microbiota after <italic>H. pylori</italic> eradication therapy.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>Using this data one can describe the general trends of the microbial composition variation caused by antibiotics and predict possible side effects.</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>The data can be used to detect the genetic markers of dysbiosis and to design a minimally invasive PCR diagnostic system.</p></list-item></list></p><sec id="s0005"><label>1</label><title>Data</title><p>The data represent the result of metagenomic shotgun-sequencing of human gut microbiota at 3 time points: before the <italic>H. pylori</italic> eradication therapy, immediately after 2 weeks of therapy and several weeks after the treatment. The dataset contains 15 metagenomic samples in raw reads format with 30.4 &#x000b1; 10.7 mln of reads per sample (mean &#x000b1; SD).</p><p>These data together with those described in [2] were involved in the study devoted to the gut microbiome changes caused by antimicrobial therapy [1].</p><p>These data together with those described in <xref rid="bib2" ref-type="bibr">[2]</xref> were involved in the study devoted to the gut microbiome changes caused by antimicrobial therapy <xref rid="bib1" ref-type="bibr">[1]</xref>.</p><p>Detailed description of samples is given in <xref rid="t0005" ref-type="table">Table 1</xref>.<table-wrap id="t0005" position="float"><label>Table 1</label><caption><p>Description of samples. &#x0201c;Time point&#x0201d; column shows the time of sample collection: &#x0201c;1&#x0201d; means at the start of the therapy, &#x0201c;2&#x0201d; &#x02013; immediately after therapy, &#x0201c;3&#x0201d; &#x02013; several weeks after therapy.</p></caption><alt-text id="at0005">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Patient ID</th><th>Gender</th><th>Diagnosis</th><th>Sample ID</th><th>Time point</th></tr></thead><tbody><tr><td rowspan="3">1</td><td rowspan="3">Male</td><td rowspan="3">Gastroesophageal reflux disease</td><td>1HP</td><td>1</td></tr><tr><td>2HP</td><td>2</td></tr><tr><td>3HP</td><td>3 (3.5 weeks after treatment)</td></tr><tr><td/><td/><td/><td/><td/></tr><tr><td rowspan="3">2</td><td rowspan="3">Male</td><td rowspan="3">Chronic gastroduodenitis</td><td>26HP</td><td>1</td></tr><tr><td>27HP</td><td>2</td></tr><tr><td>28HP</td><td>3 (4 weeks after treatment)</td></tr><tr><td/><td/><td/><td/><td/></tr><tr><td rowspan="3">3</td><td rowspan="3">Female</td><td rowspan="3">Gastroesophageal reflux disease</td><td>41HP</td><td>1</td></tr><tr><td>42HP</td><td>2</td></tr><tr><td>43HP</td><td>3 (11 weeks after treatment)</td></tr><tr><td/><td/><td/><td/><td/></tr><tr><td rowspan="3">4</td><td rowspan="3">Female</td><td rowspan="3">Chronic gastroduodenitis</td><td>31HP</td><td>1</td></tr><tr><td>53HP</td><td>2</td></tr><tr><td>54HP</td><td>3 (4 weeks after treatment)</td></tr><tr><td/><td/><td/><td/><td/></tr><tr><td rowspan="3">5</td><td rowspan="3">Male</td><td rowspan="3">Gastroesophageal reflux disease</td><td>63HP</td><td>1</td></tr><tr><td>64HP</td><td>2</td></tr><tr><td>65HP</td><td>3 (2.5 weeks after treatment)</td></tr></tbody></table></table-wrap></p></sec><sec id="s0010"><label>2</label><title>Experimental design, materials and methods</title><sec id="s0015"><label>2.1</label><title>Sample collection</title><p>Fifteen stool samples from 5 patients with symptoms of stomach and/or duodenum disease and <italic>Helicobacter pylori</italic> detected by endoscopy were taken for analysis. According to the Maastricht V Consensus and recommendations of Russian Gastroenterological Association, patients had been prescribed a two-week eradication therapy consisted of amoxicillin (1000&#x000a0;mg bid), clarithromycin (500&#x000a0;mg bid) and proton pump inhibitors at a standard dose accompanied by bismuth subsalicylate (240&#x000a0;mg bid) <xref rid="bib3" ref-type="bibr">[3]</xref>. Samples were collected in the Polyclinic Department of the Republican Clinical Hospital #2 (Kazan). The study was approved by the Local Ethics Committee of the Kazan Federal University. Prior written informed consent was obtained from all patients.</p></sec><sec id="s0020"><label>2.2</label><title>Sample preparation and sequencing</title><p>Fecal samples were collected in the individual plastic containers, avoiding contamination with urine or toilet tissue. 10&#x02013;20&#x000a0;g of samples were instantly frozen with subsequent storage at &#x02212;20&#x000a0;&#x000b0;C, or were used for DNA extraction immediately after sampling.</p><p>Total DNA (5&#x000a0;&#x003bc;g) from fecal samples was extracted using the Purelink Genomic DNA Extraction Kit (Invitrogen, USA). Metagenomic single-end library preparation and shotgun sequencing on SOLiD 5500&#x000a0;W platform was performed according to the recommendations of the manufacturer (LifeTechnologies, USA). The resulting color-spaced reads with length of 50&#x000a0;bp were converted to the base-space format.</p></sec></sec></body><back><ref-list id="bibliog0005"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref1"><person-group person-group-type="author"><name><surname>Khusnutdinova</surname><given-names>D.</given-names></name><name><surname>Grigoryeva</surname><given-names>T.</given-names></name><name><surname>Abdulkhakov</surname><given-names>S.</given-names></name><name><surname>Safina</surname><given-names>D.</given-names></name><name><surname>Siniagina</surname><given-names>M.</given-names></name><name><surname>Markelova</surname><given-names>M.</given-names></name><name><surname>Boulygina</surname><given-names>E.</given-names></name><name><surname>Malanin</surname><given-names>S.</given-names></name><name><surname>Tyakht</surname><given-names>A.</given-names></name><name><surname>Kovarsky</surname><given-names>B.</given-names></name><name><surname>Ismagilova</surname><given-names>R.</given-names></name><name><surname>Abdulkhakov</surname><given-names>R.</given-names></name><name><surname>Chernov</surname><given-names>V.</given-names></name></person-group><article-title>Gut microbiome shotgun sequencing in assessment of microbial community changes associated with <italic>H. pylori</italic> eradication therapy</article-title><source>BioNanoScience</source><volume>6</volume><issue>4</issue><year>2016</year><fpage>585</fpage><lpage>587</lpage></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref2"><person-group person-group-type="author"><name><surname>Glushchenko</surname><given-names>O.</given-names></name><name><surname>Samoilov</surname><given-names>A.</given-names></name><name><surname>Olekhnovish</surname><given-names>E.</given-names></name><name><surname>Kovarsky</surname><given-names>B.</given-names></name><name><surname>Tyakht</surname><given-names>A.</given-names></name><name><surname>Pavlenko</surname><given-names>A.</given-names></name><name><surname>Babenko</surname><given-names>V.</given-names></name><name><surname>Larin</surname><given-names>A.</given-names></name><name><surname>Kostryukova</surname><given-names>E.</given-names></name><name><surname>Malakhova</surname><given-names>M.</given-names></name><name><surname>Ilina</surname><given-names>E.</given-names></name><name><surname>Abdulkhakov</surname><given-names>R.</given-names></name><name><surname>Safina</surname><given-names>D.</given-names></name><name><surname>Grigoryeva</surname><given-names>T.</given-names></name><name><surname>Abdulkhakov</surname><given-names>S.</given-names></name><name><surname>Govorun</surname><given-names>V.</given-names></name></person-group><article-title>Data on gut metagenomes of the patients with <italic>Helicobacter pylori</italic> infection before and after the antibiotic therapy</article-title><source>Data Brief</source><volume>11</volume><year>2017</year><fpage>68</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">28138506</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref3"><person-group person-group-type="author"><name><surname>Malfertheiner</surname><given-names>P.</given-names></name><name><surname>Megraud</surname><given-names>F.</given-names></name><name><surname>O'Morain</surname><given-names>C.A.</given-names></name><name><surname>Gisbert</surname><given-names>J.P.</given-names></name><name><surname>Kuipers</surname><given-names>E.J.</given-names></name><name><surname>Axon</surname><given-names>A.T.</given-names></name><name><surname>Bazzoli</surname><given-names>F.</given-names></name><name><surname>Gasbarrini</surname><given-names>A.</given-names></name><name><surname>Atherton</surname><given-names>J.</given-names></name><name><surname>Graham</surname><given-names>D.Y.</given-names></name><name><surname>Hunt</surname><given-names>R.</given-names></name><name><surname>Moayyedi</surname><given-names>P.</given-names></name><name><surname>Rokkas</surname><given-names>T.</given-names></name><name><surname>Rugge</surname><given-names>M.</given-names></name><name><surname>Selgrad</surname><given-names>M.</given-names></name><name><surname>Suerbaum</surname><given-names>S.</given-names></name><name><surname>Sugano</surname><given-names>K.</given-names></name><name><surname>El-Omar</surname><given-names>E.M.</given-names></name><collab>The European Helicobacter Study Group</collab></person-group><article-title>Management of <italic>Helicobacter pylori</italic> infection &#x02014; the Maastricht V/Florence consensus report</article-title><source>Gut</source><year>2016</year></element-citation></ref></ref-list><sec id="s0030" sec-type="supplementary-material"><label>Transparency document</label><title>Supplementary material</title><p><fig id="f0005" position="anchor"><label>Fig. S1</label><alt-text id="at0015">Fig. S1</alt-text><graphic xlink:href="mmc1"/></fig></p></sec><ack id="ack0005"><title>Acknowledgements</title><p>This work was financially supported by the <funding-source id="gs1">Ministry of Education and Science of Russian Federation</funding-source> (Agreement no. 14.575.21.0076, ID RFMEFI575I4&#x000d7;0076).</p></ack><fn-group><fn id="s0025" fn-type="supplementary-material"><label>Transparency document</label><p>Transparency data associated with this article can be found in the online version at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.dib.2017.07.070" id="ir0007">http://dx.doi.org/10.1016/j.dib.2017.07.070</ext-link>.</p></fn></fn-group></back></article>